Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
| dc.contributor.author | Powell, Matthew A. | |
| dc.contributor.author | Hietanen, Sakari | |
| dc.contributor.author | Coleman, Robert L. | |
| dc.contributor.author | Monk, Bradley J. | |
| dc.contributor.author | Zub, Oleksandr | |
| dc.contributor.author | O'Malley, David M. | |
| dc.contributor.author | Gilbert, Lucy | |
| dc.contributor.author | Podzielinski, Iwona | |
| dc.contributor.author | Angioli, Roberto | |
| dc.date.accessioned | 2023-11-26T11:32:04Z | |
| dc.date.available | 2023-11-26T11:32:04Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Пацієнти (пацієнти) з первинною прогресуючою стадією III або IV або першим рецидивним раком ендометрыю були рандомізовані 1:1 для отримання достарлімабу 500 мг або PBO плюс карбоплатину AUC 5 і паклітакселу 175 мг/м2 Q3W (6 циклів), потім достарлімабу 1000 мг , або PBO, монотерапія Q6W до 3 років. | en_US |
| dc.identifier.citation | Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) / M. A. Powell, S.Hietanen, R. L. Coleman, B. J. Monk, O. Zub [et al.] // Journal of Clinical Oncology. – 2023. – № 16. – P. 5503. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/33057 | |
| dc.language.iso | en_US | en_US |
| dc.subject | standard of care | en_US |
| dc.subject | anti–programmed death | en_US |
| dc.subject | carboplatin paclitaxel | en_US |
| dc.subject | 2023а | en_US |
| dc.title | Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY). | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- powell-et-al-2023-dostarlimab-for-primary-advanced-or-recurrent-(a-r)-endometrial-cancer-(ec)-outcomes-by-blinded.pdf
- Size:
- 38.61 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 11.22 KB
- Format:
- Item-specific license agreed upon to submission
- Description: